31. August 2020

Qmedics Peripheral stent system family

Exist, Falcor and Draco

After two and a half years of hard work finally we present the new peripheral stent family.
It was a difficult path: The R&D efforts where enormous, as designing a stent portfolio that has a disease (PAD) as indication with a stent design that has to take into account both movability and lesion characteristics was for our engineers a tremendous challenge.

The regulatory hurdles were associated with long-term stress, tension, many uncertainties, long waiting times at the notified body and if this was not enough the COVID-19 came along. But we made it thanks to all who did believe in the project and didn’t give up.

Our novel SDS portfolio tackles the PAD complexity in terms of artery in-vivo loading, lesion characteristics and movability of the artery hereby giving the operator a wider choice of solutions to treat the patient.

The new stent portfolio has three variants 4F, 5F & 6F variant has two types. A Pull type with a higher radial force, engineered to provide a perfect balance between compression resistance and longitudinal conformability without sacrificing flexibility. The Flex type can act as a strong scaffold, provides flexibility without sacrificing radial strength, provide high acceptance towards bending, and compression. We are proud to present Exist 6F, Falcor 5F and Draco 4F.

30. July 2020

PTA Qmedics product family Manatee-Naga-Nova is launched

The rise in the prevalence of cardiovascular diseases and peripheral vascular diseases, adaptation to a sedentary lifestyle, better healthcare facilities are key factors contributing to increase of the PTA balloon market during the last few years. According to the current market analysis the global PTA balloon Catheter market is still expected to double in the next coming years.

Qmedics sparing no expense or efforts, took on the courage & challenge to meet the high regulatory requirements had a lot of patience during the difficult COVID time where the Notified body approvals took forever.
We can proudly announce the CE certification of the new PTA balloon family portfolio: Manatee 6F-Naga 5F & Nova 4F

The Qmedics PTA balloon family has a wide spread of sizes that treat more lesions and locations.

The new portfolio is totally manufactured at the Qmedics facility- from raw material to the final sterilized product. Qmedics controls each and all processes of the manufacturing and has no external processes.

This is the Qmedics back-bone of our Swiss quality.